Healthcare
Live Price
Offline$4.00
+0.00% today
1Y Change
+0.00%
Window
Jun 26, 2025 → Jun 25, 2026
Coverage: 256 bars · Jun 26, 2025 → Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) is a Healthcare stock with a market cap of $40.73B and listed on OTC. The stock last traded around $4.00 and up 0.0% across the available one-year price window (Jun 26, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of +3.5%, EPS growth of +121.3%, a dividend yield of 0.5%. What stands out right now is revenue +3.5%, EPS +121.3%, free cash flow +22.0% with operating margin 18.0% and ROIC 3.9%. The dividend is present but secondary, with a yield around 0.5%. Valuation already assumes a fairly strong business story at P/E 58.5 and price/sales 5.8. Stock Foundry combines HNGZY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HNGZY
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HNGZY Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for HNGZY and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
0.54%
Trailing 12M Payout
$0.00
Last Payout
| Ex-Date | Record | Pay | Dividend | Adj | Frequency |
|---|---|---|---|---|---|
| Jun 13, 2025 | Jun 13, 2025 | Aug 14, 2025 | $0.03 | $0.03 | Annual |
| Jun 11, 2024 | Jun 11, 2024 | Aug 1, 2024 | $0.06 | $0.06 | Annual |
| May 25, 2023 | May 26, 2023 | Jul 21, 2023 | $0.06 | $0.06 | Annual |
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.